Cardiol Therapeutics (CRDL) Other Working Capital Changes (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Other Working Capital Changes came in at -$10095.1 in Q1 2026, down 4.63% YoY from -$10585.6 in Q1 2025, and little changed on a QoQ basis from -$10059.5 in Q3 2025.
Cardiol Therapeutics (CRDL) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Other Working Capital Changes data on file, last reported at -$10095.1 in Q1 2026.
- Quarterly Other Working Capital Changes fell 4.63% year-over-year to -$10095.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$39794.2 (down 32.41% YoY) and the FY2021 annual result came in at -$41426.7, down 9.95% from the prior year.
- Other Working Capital Changes was little changed at -$10095.1 in Q1 2026, from -$10059.5 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $757584.4 in Q3 2022 to a low of -$1.0 million in Q1 2026.
- A 5-year average of -$14039.8 and a median of $210370.7 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes jumped 67.24% — and 2025, when it tumbled 197.35%.
- Tracing CRDL's Other Working Capital Changes over 5 years: stood at -$10614.8 in 2022, then increased by 2.71% to -$10326.7 in 2023, then jumped by 67.24% to -$3383.0 in 2024, then plunged by 197.35% to -$10059.5 in 2025, then dropped by 0.35% to -$10095.1 in 2026.
- The last three Other Working Capital Changes figures came in at -$10095.1 (Q1 2026), -$10059.5 (Q3 2025), and -$9991.4 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,095.12 |
| Mar 31, 2026 | -10,095.12 |
| Mar 31, 2026 | -10,095.12 |
| Sep 30, 2025 | -10,059.53 |
| Sep 30, 2025 | -10,059.53 |
| Sep 30, 2025 | -10,059.53 |
| Jun 30, 2025 | -9,991.39 |
| Jun 30, 2025 | -9,991.39 |
| Jun 30, 2025 | -9,991.39 |
| Mar 31, 2025 | -9,648.11 |
| Mar 31, 2025 | -9,648.11 |
| Mar 31, 2025 | -9,648.11 |
| Sep 30, 2024 | -3,383.04 |
| Sep 30, 2024 | -3,383.04 |
| Sep 30, 2024 | -3,383.04 |
| Jun 30, 2024 | -6,747.70 |
| Jun 30, 2024 | -6,747.70 |
| Jun 30, 2024 | -6,747.70 |
| Mar 31, 2024 | -10,273.82 |
| Mar 31, 2024 | -10,273.82 |